Utah Retirement Systems lifted its stake in Monsanto Company (NYSE:MON) by 0.5% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 80,363 shares of the basic materials company’s stock after acquiring an additional 400 shares during the period. Utah Retirement Systems’ holdings in Monsanto were worth $9,511,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also made changes to their positions in MON. Acrospire Investment Management LLC bought a new stake in Monsanto during the 1st quarter worth about $113,000. Pinnacle Financial Partners Inc. acquired a new position in Monsanto in the second quarter valued at approximately $114,000. JNBA Financial Advisors boosted its stake in Monsanto by 3.9% during the 1st quarter. JNBA Financial Advisors now owns 1,193 shares of the basic materials company’s stock worth $135,000 after acquiring an additional 45 shares during the last quarter. Armbruster Capital Management Inc. increased its position in shares of Monsanto by 12.2% during the second quarter. Armbruster Capital Management Inc. now owns 1,147 shares of the basic materials company’s stock worth $136,000 after acquiring an additional 125 shares in the last quarter. Finally, Penserra Capital Management LLC raised its holdings in shares of Monsanto by 9.5% in the first quarter. Penserra Capital Management LLC now owns 1,288 shares of the basic materials company’s stock valued at $145,000 after purchasing an additional 112 shares during the last quarter. Hedge funds and other institutional investors own 74.78% of the company’s stock.
A number of research analysts have recently commented on MON shares. Zacks Investment Research raised shares of Monsanto from a “hold” rating to a “buy” rating and set a $132.00 price objective for the company in a research report on Friday, June 16th. Vetr raised Monsanto from a “hold” rating to a “buy” rating and set a $122.35 target price on the stock in a research report on Wednesday, July 12th. Piper Jaffray Companies set a $128.00 price objective on shares of Monsanto and gave the company a “buy” rating in a report on Friday, August 11th. BMO Capital Markets reiterated a “buy” rating and set a $128.00 target price on shares of Monsanto in a research report on Friday, September 1st. Finally, Barclays PLC upped their price target on shares of Monsanto from $115.00 to $120.00 and gave the stock an “equal weight” rating in a report on Thursday, June 29th. Ten investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $124.09.
In other Monsanto news, EVP Robert T. Fraley sold 52,410 shares of Monsanto stock in a transaction that occurred on Monday, July 10th. The stock was sold at an average price of $117.95, for a total value of $6,181,759.50. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP Steven Mizell sold 11,300 shares of the business’s stock in a transaction that occurred on Monday, July 3rd. The stock was sold at an average price of $118.57, for a total value of $1,339,841.00. Following the sale, the executive vice president now directly owns 55,011 shares in the company, valued at approximately $6,522,654.27. The disclosure for this sale can be found here. 0.79% of the stock is owned by company insiders.
Monsanto Company (NYSE:MON) opened at 119.77 on Friday. The company has a market cap of $52.62 billion, a P/E ratio of 25.87 and a beta of 1.07. Monsanto Company has a 12-month low of $97.35 and a 12-month high of $119.82. The firm has a 50-day moving average price of $117.37 and a 200-day moving average price of $116.53.
Monsanto (NYSE:MON) last posted its earnings results on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.74 by $0.19. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. The company had revenue of $4.23 billion during the quarter, compared to analysts’ expectations of $4.18 billion. During the same quarter last year, the firm earned $2.17 earnings per share. The firm’s quarterly revenue was up 1.0% compared to the same quarter last year. On average, equities research analysts forecast that Monsanto Company will post $4.89 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, October 6th will be issued a $0.54 dividend. The ex-dividend date of this dividend is Thursday, October 5th. This represents a $2.16 dividend on an annualized basis and a yield of 1.80%. Monsanto’s dividend payout ratio (DPR) is presently 46.75%.
ILLEGAL ACTIVITY WARNING: This piece of content was first published by BBNS and is the property of of BBNS. If you are viewing this piece of content on another site, it was copied illegally and reposted in violation of US and international copyright laws. The legal version of this piece of content can be read at https://baseballnewssource.com/markets/utah-retirement-systems-has-9-51-million-position-in-monsanto-company-mon/1603658.html.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with our FREE daily email newsletter.